Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study

International Journal of Cardiology

Volumn 209, Issue , 2016, Pages 20-21

  Toušek, Petr ^a   Kočka, Viktor ^a   Malý, Martin ^b   Kozel, Martin ^a   Robert, Petr ^b   Hajšl, Martin ^a   Jarkovský, Jiří ^c   Widimský, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Bioresorbable vascular scaffold; Dual antiplatelet treatment termination; Long term follow up; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; PURINERGIC RECEPTOR BLOCKING AGENT; EVEROLIMUS;

ARTICLE; BARE METAL STENT; BIORESORBABLE VASCULAR STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVENT FREE SURVIVAL; EVEROLIMUS ELUTING CORONARY STENT; FOLLOW UP; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT MALAPPOSITION; STENT THROMBOSIS; TREATMENT OUTCOME; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; CZECH REPUBLIC; EPIDEMIOLOGY; MORTALITY; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TRENDS;

ABSORBABLE IMPLANTS; CZECH REPUBLIC; DRUG-ELUTING STENTS; EVEROLIMUS; FOLLOW-UP STUDIES; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; PROSPECTIVE STUDIES; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE;

EID: 84961721985     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.02.029     Document Type: Article

References (10)

1. A. Abizaid, J. Ribamar Costa Jr., A.L. Bartorelli, R. Whitbourn, R.J. van Geuns, B. Chevalier, and et al. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled EuroIntervention 10 2015 1396 1401
2. P.W. Serruys, B. Chevalier, D. Dudek, A. Cequier, D. Carrie, A. Iniguez, and et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
3. V. Kocka, M. Maly, P. Tousek, T. Budesinsky, L. Lisa, P. Prodanov, and et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19' Eur. Heart J. 35 2014 787 794
4. P.W. Serruys, Y. Onuma, H.M. Garcia-Garcia, T. Muramatsu, R.J. van Geuns, B. de Bruyne, and et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention 9 2014 1271 1284
5. S. Brugaletta, T. Gori, A.F. Low, P. Tousek, E. Pinar, J. Gomez-Lara, and et al. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS- EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction) J. Am. Coll. Cardiol. Intv. 8 2015 189 197
6. P. Widimsky, R. Petr, P. Tousek, M. Maly, H. Linkova, J. Vrana, and et al. One-year clinical and computed tomography angiographic outcomes after bioresorbable vascular scaffold implantation during primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: the PRAGUE-19 study Circ. Cardiovasc. Interv. 8 2015
7. L. Raber, T. Zanchin, S. Baumgartner, M. Taniwaki, B. Kalesan, A. Moschovitis, and et al. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study Int. J. Cardiol. 173 2014 259 267
8. P.W. Serruys, Y. Onuma, J.A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, and et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
9. L. Raber, S. Brugaletta, K. Yamaji, C.J. O'Sullivan, S. Otsuki, T. Koppara, and et al. Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings J. Am. Coll. Cardiol. 66 2015 1901 1914
10. M. Sabate, S. Windecker, A. Iniguez, L. Okkels-Jensen, A. Cequier, S. Brugaletta, and et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial Eur. Heart J. 37 2016 229 240